Atishay Ltd Secures International Contract for AI-Powered Diagnostic Platform Development
Atishay Ltd has secured a significant international contract, signing a software development agreement with Global Top Link Technologies Company Limited in Myanmar. The deal encompasses the design, development, and deployment of an AI-Powered Centralized Diagnostic Platform, Phase I.This engagement marks Atishay’s inaugural international work order within the specialized field of AI Diagnostics, highlighting the company's growing global recognition and technical execution capabilities. The contract is designed to strengthen Atishay’s portfolio in advanced AI-driven healthcare solutions.
The scope of the project includes the design, development, deployment, and maintenance of a comprehensive AI-powered centralized diagnostic software platform. This platform incorporates artificial intelligence orchestration, clinical workflow management, specialist review functionalities, and robust reporting modules.
The financial terms and timelines for this international contract are as follows:
| Component | Details |
|---|---|
| Client Name | Global Top Link Technologies Company Limited, Myanmar |
| Phase I Development Fee | USD 295,740 |
| Maintenance & Support | USD 80,000 per annum |
| Execution Timeline (Phase I) | Six months from commencement date |
| Service Period | Twelve months of maintenance and support following Phase I completion |
The contract is structured as a fixed fee, milestone-linked engagement. The payments are connected to the acceptance of defined module milestones and include provisions for both a mobilization advance and a retention component.
The agreement does not involve any related party transactions, and neither Atishay's promoters nor its group companies hold an interest in Global Top Link Technologies Company Limited. This partnership reaffirms the company’s commitment to delivering cutting-edge technology solutions on a global scale.
Stock Price Movement
As of 13:44, Atishay Ltd's shares are trending downward, currently trading at ₹154.75, registering a decline of 9.87% for the day. The stock moved through a significant intraday range, having been tested against highs near ₹171.55 and lows as low as ₹152.30.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.